Skip to Main content Skip to Navigation
Journal articles

Enquête sur la pratique du dépistage du VIH, VHB et VHC en cancérologie, France

Abstract : HIV testing is recommended at time of cancer diagnosis, HBV and HCV screening because of the risk of reactivation with certain anticancer drugs.This is a cross-sectional study. The objectives were to assess the screening practices in cancer patients and the satisfaction of professionals in the event of use of the CancerHIV network. A questionnaire drafted by the CancerHIV expert and the OncoPaca-Corse Regional Cancer Network (RCN) was distributed in the region at the end of 2018 (part 1: V1) before being extended to the national level via the CancerHIV network (part 2: V2). Participation reached 160 and 130 respondents (V1 and V2, respectively). At the initial cancer assessment, 23% of respondents declared that they systematically screened for HIV at V1 (V2: 17%), 25% for HBV (V2: 20%) and 24% for HCV (V2: 19%). Before immunotherapy, the rates were 54% for HIV in V1 (V2: 52%), 57% for HBV (V2: 60%) and 55% for HCV (V2: 57%). Among the respondents, satisfaction when requesting a regional or national remedy was high (almost 100%). Screening for HIV, HBV and HCV allows supervised prescription of immunosuppressive or cytotoxic treatment to a potentially immunosuppressed patient. This study, resulting of an original collaboration between a RCN and a national expert network, underlines the lack of screening at the 2 examined stages of patient care, and the need for raising practitioners' awareness to recommendations.
Document type :
Journal articles
Complete list of metadata
Contributor : Odile Malbec <>
Submitted on : Friday, September 3, 2021 - 4:47:42 PM
Last modification on : Wednesday, September 8, 2021 - 3:34:07 AM


 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document



Myriam Taouqi, Marianne Veyri, Sylvie Brégigeon, Michèle Pibarot, Caroline Solas, et al.. Enquête sur la pratique du dépistage du VIH, VHB et VHC en cancérologie, France. Bulletin du Cancer, John Libbey Eurotext, 2021, 108 (4), pp.369 - 376. ⟨10.1016/j.bulcan.2020.11.019⟩. ⟨inserm-03334396⟩



Record views